Colorectal Cancer Survivors Suffering From Sensory Chemotherapy-Induced Peripheral Neuropathy Are Not a Homogenous Group: Secondary Analysis of Patients' Profiles With Oxaliplatin-Induced Peripheral Neuropathy

• Main Authors: Nicolas Kerckhove (Author), Marie Selvy (Author), Céline Lambert (Author), Coralie Gonneau (Author), Gabrielle Feydel (Author), Caroline Pétorin (Author), Agnès Vimal-Baguet (Author), Sergey Melnikov (Author), Sharif Kullab (Author), Mohamed Hebbar (Author), Olivier Bouché (Author), Florian Slimano (Author), Vincent Bourgeois (Author), Valérie Lebrun-Ly (Author), Frédéric Thuillier (Author), Thibault Mazard (Author), David Tavan (Author), Kheir Eddine Benmammar (Author), Brigitte Monange (Author), Mohamed Ramdani (Author), Denis Péré-Vergé (Author), Floriane Huet-Penz (Author), Ahmed Bedjaoui (Author), Florent Genty (Author), Cécile Leyronnas (Author), Jérôme Busserolles (Author), Sophie Trévis (Author), Vincent Pinon (Author), Denis Pezet (Author), David Balayssac (Author)
• Format: Book
• Published: Frontiers Media S.A., 2021-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Oxaliplatin, a pivotal drug in the management of colorectal cancer, causes chemotherapy-induced peripheral neuropathy (CIPN) in a third of cancer survivors. Based on a previous cross-sectional study assessing oxaliplatin-related sensory CIPN in colorectal cancer survivors, a secondary analysis was d...